Search for Clinical Trial Results

Sponsored By

Pigmented Villonodular Synovitis - 8 Studies Found

Status Study
Completed Study Name: Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)
Condition: Pigmented Villonodular Synovitis
Date: 2010-12-15
Interventions: Drug: Tasigna The study drug is nilotinib (Tasigna®).
Recruiting Study Name: Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Condition:
  • Pigmented Villonodular Synovitis
  • Tenosyno
    Date: 2015-06-01
    Interventions: Drug: FPA008 FPA008 will be administered by IV infusion over approximately 30 minutes every 2 weeks
Active, not recruiting Study Name: PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
Condition:
  • Pigmented Villonodular Synovitis
  • Giant Cell Tumors of the Tendo
    Date: 2015-02-19
    Interventions:
    • Drug: PLX3397 capsule Each cap
Active, not recruiting Study Name: Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
Condition:
  • Pigmented Villonodular Synovitis
  • Diffuse-type Giant Cell Tumor<
    Date: 2010-09-21
    Interventions: Drug: nilotinib Taken orally twice daily
Recruiting Study Name: MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCTTS)
Condition:
  • Pigmented Villonodular Synovitis
  • PVNS
  • Drug: MCS110 Patients will rec
Recruiting Study Name: A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
Condition:
  • Solid Tumors
  • Tenosynovial Giant Cell Tumor
  • Solid Tumor
  • Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutation
    Date: 2013-03-01
    Interventions: Drug: PLX7486 TsOH PLX7486 TsOH capsules, 50mg